-
Featured
Confronting the Opioid Epidemic in the OB/GYN Practice: Optimizing Prescribing Habits and Reducing Opioid Misuse
Researchers in the OB/GYN Department are working to combat the opioid epidemic and mitigate its effects. Recent efforts have focused on preventing opioid use and misuse through a variety of methods including optimized prescribing practices.
-
Featured
Fighting Zika Virus on Multiple Fronts: Identifying Risk, Improving Screening and Investigating Pregnant Women's Vaccination Attitudes
Obstetricians at Mass General are working to fight the Zika epidemic on multiple fronts by guiding decision-making about testing for Zika infection, filling knowledge gaps about Zika risks and develop testing protocols and understanding pregnant women’s attitudes about Zika vaccines to help guide vaccine development.
-
Featured
Perinatal Substance Use Clinic: Multidisciplinary Care from Pregnancy to Early Childhood
A multidisciplinary, 1000-day clinical model offers a new approach to prenatal and postnatal care for mothers with opioid use disorder and their children.
-
Maternal and Placental Immune Responses to SARS-CoV-2 Differ by Fetal Sex
Massachusetts General Hospital researchers present evidence that fetal sex plays a key role in modifying maternal humoral responses and placental innate and adaptive immune responses. They found significantly reduced transfer of SARS-CoV-2–specific antibodies to male fetuses.
-
Childbirth Often Traumatic for Women with COVID-19
Massachusetts General Hospital researchers found that 49% of women with COVID-19 endorsed an acute traumatic stress response to childbirth, and compared to women without COVID-19, they reported higher levels of pain during delivery and double the odds of delivering an infant who required neonatal ICU admission.
-
Risk Score for Maternal Morbidity Can Also Predict Postpartum Hemorrhage
Maternal-fetal medicine specialists at Massachusetts General Hospital found that the Expanded Obstetric Comorbidity Score (EOCS), a risk-stratification tool recently developed for predicting severe maternal morbidity, can also be used to predict which women in labor are at risk of postpartum hemorrhage.
Obstetrics Contributors
-
Davida M. Schiff, MD
Medical Director, HOPE Clinic, Instructor, Pediatrics, Harvard Medical School
Recent Article
Racial/Ethnic Disparities Evident in Medical Treatment of Opioid Use Disorder During Pregnancy
-
Ilona T. Goldfarb, MD
Maternal Fetal Medicine Specialist, Massachusetts General Hospital
Recent Article
No Link Between COVID-19 and Stillbirth Detected, But Placental Vascular Pathology is Worrisome
-
Jeffrey L. Ecker, MD
Chief, Department of Obstetrics & Gynecology
Recent Article
Mass General Department of OB/GYN Develops and Executes Three-Pronged Diversity Strategy
-
Jessica R. Gray, MD
Clinical director, HOPE Clinic, Family medicine addiction specialist
Recent Article
Perinatal Substance Use Clinic: Multidisciplinary Care from Pregnancy to Early Childhood
-
Sarah N. Bernstein, MD
Maternal Fetal Medicine Specialist, Medical director, Outpatient Obstetrics Program
Recent Article
Managing the Cardiovascular Complications of Substance Use Disorders During Pregnancy
-
William H. Barth, MD
Vice Chair, Obstetrics
Recent Article
Percutaneous Valve Replacement Therapy Sometimes an Option During Pregnancy
Obstetrics & Gynecology Care at Mass General
The Mass General Department of Obstetrics & Gynecology offers the highest level of care to women. Our clinical and research team is a leader in advancing treatments for gynecologic cancers, menopause, high-risk obstetrics, infertility and urogynecology.
